DSM Looks to Diabetes Management

31/08/07 DSM has announced the launch of a unique ingredient which represents a breakthrough in diabetes management.  For the first time manufacturers can create products clinically proven to help type 2 diabetes patients actively control glucose levels after mealtimes. InsuVital is a natural, extensively hydrolysed casein consisting of bioactive peptides which work with the body to release insulin after intake.  This results in a reduction in glucose levels post-meal similar to those seen in non-diabetics and improved overall blood sugar control.  A highly versatile powder, InsuVital can be incorporated into a wide range of functional food and beverage applications.

Clinical trials have shown that consuming foods containing InsuVital both stimulates insulin secretion and improves glucose disposal. Not only is this new ingredient beneficial to those patients already diagnosed with type 2 diabetes, it also responds to the growing need for a food-based solution that will help slow down the onset and progress of (pre)diabetes.

“The number of people suffering from type 2 diabetes is rising rapidly and diet is seen as a key factor in their wellbeing,” comments Erik Lommerde, Business Manager Metabolic Syndrome and Diabetes, DSM.  “Diabetes is an international health issue with an estimated 6% of the global adult population already suffering from the disease.  In response, DSM has developed a truly innovative product for both diabetics and pre-diabetics which offers a safe way to help control blood sugar as part of a healthy balanced diet.  Products containing InsuVital start working from the very first mouthful to lower blood glucose peaks. It is a convenient way to help manage the condition of diabetes and pre-diabetes which, alongside diet and lifestyle changes, is designed to put the individual back in control – an approach which we know will have strong appeal with this audience and heavily endorsed by diabetes organisations.”